Valuation Metrics and Recent Changes
As of 9 April 2026, Mangalam Organics trades at ₹435.95, up 8.46% from the previous close of ₹401.95. The stock’s 52-week range spans from ₹339.00 to ₹654.05, indicating a significant recovery from its lows but still below its peak levels. The company’s P/E ratio currently stands at 13.53, a figure that has contributed to the upgrade in its valuation grade from very attractive to attractive. This P/E is modest when compared to many peers in the commodity chemicals industry, where valuations often exceed 20 times earnings.
The price-to-book value ratio is 1.21, suggesting the stock is trading close to its book value, which is generally considered reasonable for a micro-cap chemical company. Other valuation multiples include an EV/EBITDA of 11.87 and an EV/EBIT of 18.91, both indicating moderate valuation levels relative to earnings and operating profits.
Peer Comparison Highlights
When compared with peers, Mangalam Organics’ valuation appears more attractive. For instance, Titan Biotech is classified as very expensive with a P/E of 72.63 and EV/EBITDA of 59.18, while Stallion India trades at a P/E of 33.96 and is also deemed very expensive. Sanstar and Jyoti Resins similarly carry expensive valuations with P/E ratios above 14. In contrast, Mangalam’s P/E of 13.53 and EV/EBITDA of 11.87 place it comfortably in the attractive category.
Interestingly, some peers such as TGV Sraac and Gulshan Polyols are rated very attractive, with TGV Sraac’s P/E at 8.7 and EV/EBITDA at 3.98, and Gulshan Polyols at a P/E of 25.2 but with a strong PEG ratio of 0.12. I G Petrochems is noted as very attractive but is loss-making, which complicates direct valuation comparisons.
Financial Performance and Returns
Mangalam Organics’ return metrics present a mixed picture. Year-to-date, the stock has declined by 11.57%, slightly underperforming the Sensex’s 8.99% decline. However, over the past week and month, the stock has outperformed the benchmark significantly, with returns of 15.27% and 6.03% respectively, compared to Sensex gains of 6.06% and a decline of 1.72% over the same periods.
Longer-term returns show a more nuanced trend. Over one year, Mangalam has delivered a 3.55% return, slightly below the Sensex’s 4.49%. Over three years, the stock has gained 21.81%, lagging the Sensex’s 29.63%. The five-year return is negative at -17.35%, contrasting sharply with the Sensex’s robust 55.92% gain. However, the ten-year return is spectacular at 2135.64%, vastly outperforming the Sensex’s 214.35%, underscoring the company’s long-term growth potential despite recent volatility.
Profitability and Efficiency Metrics
Profitability ratios remain modest. The latest return on capital employed (ROCE) is 5.37%, while return on equity (ROE) stands at 8.72%. These figures suggest that while the company is generating positive returns, there is room for improvement in capital efficiency and shareholder value creation. The PEG ratio of 0.08 indicates that earnings growth is favourable relative to the price, supporting the attractive valuation rating.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Market Capitalisation and Analyst Ratings
Mangalam Organics is classified as a micro-cap stock, which inherently carries higher volatility and risk compared to larger peers. The company’s Mojo Score currently stands at 48.0, with a Mojo Grade of Sell, downgraded from Hold on 10 December 2025. This downgrade reflects concerns over the company’s financial health, growth prospects, or market conditions, despite the improved valuation parameters.
Investors should weigh the attractive valuation against the Sell rating and micro-cap risks. The recent price appreciation of 8.46% in a single day indicates renewed investor interest, possibly driven by the valuation upgrade and improving market sentiment in the commodity chemicals sector.
Sector Context and Industry Dynamics
The commodity chemicals sector remains cyclical and sensitive to raw material price fluctuations, regulatory changes, and global demand patterns. Mangalam Organics’ valuation improvement may signal market expectations of stabilising input costs or better earnings visibility. However, the company’s modest ROCE and ROE suggest that operational efficiencies and profitability enhancements will be critical to sustaining investor confidence.
Comparing Mangalam Organics to its peers highlights the valuation disparity within the sector. While some companies command very expensive multiples due to superior growth or market positioning, Mangalam’s attractive valuation could appeal to value-oriented investors seeking exposure to commodity chemicals without paying a premium.
Holding Mangalam Organics Ltd from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investment Implications and Outlook
The shift in Mangalam Organics’ valuation grade from very attractive to attractive suggests that the stock is no longer undervalued to the same extent as before, but still offers a compelling entry point relative to many peers. The P/E ratio of 13.53 is reasonable for the sector, especially given the company’s PEG ratio of 0.08, indicating undervaluation relative to earnings growth potential.
However, the downgrade to a Sell rating and the company’s micro-cap status warrant caution. Investors should monitor quarterly earnings, margin trends, and sector developments closely. The stock’s recent outperformance over short-term periods versus the Sensex is encouraging, but longer-term returns have been mixed, with significant underperformance over five years.
Ultimately, Mangalam Organics may suit investors with a higher risk appetite seeking value plays in commodity chemicals, but it remains essential to balance valuation appeal with operational and market risks.
Conclusion
Mangalam Organics Ltd’s valuation parameters have improved, reflecting a more attractive price level relative to earnings and book value. While the company’s P/E and EV/EBITDA multiples remain modest compared to expensive peers, the downgrade in analyst rating and modest profitability metrics temper enthusiasm. Investors should consider the stock’s micro-cap risks and sector cyclicality alongside its valuation appeal. The recent price momentum and valuation upgrade may offer a tactical opportunity, but a cautious approach is advisable given the mixed financial performance and market outlook.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
